Lexeo Therapeutics (NASDAQ:LXEO) Research Coverage Started at JPMorgan Chase & Co.
JPMorgan Chase & Co. initiated coverage on shares of Lexeo Therapeutics (NASDAQ:LXEO – Free Report) in a research report report published on Tuesday, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $20.00 target price on the stock. Several other analysts also recently weighed in on LXEO. Stifel Nicolaus began coverage on Lexeo […]
More Stories
United Airlines Says Ticket Prices May Rise by up to 20 Percent to Offset Jet Fuel Surge
By Guy Birchall United Airlines may have to raise ticket prices by up to 20 percent to offset the spike...
Trump Says Iran Is Without a Leader, ‘Infighting’ Creating Confusion
By Jack Phillips U.S. President Donald Trump said he believes the Iranian regime is effectively without a leader and is...
Treasury Sanctions International Drug Network Tied to Sinaloa Cartel
By Andrew Moran The Treasury Department has introduced sanctions on 23 individuals and organizations involved in a sophisticated synthetic‑opioid procurement...
US Government to Implement New Credit Score Models for Mortgages
By Naveen Athrappully The Federal Housing Administration (FHA) has joined with Fannie Mae and Freddie Mac to implement new mortgage...
Lee Dong Wook Has Joined Netflix’s Upcoming Series, The Facade of Love
Netflix’s upcoming series, The Facade of Love, is a romantic Korean series that is based on a one-night accident that...
Little Brother, John Cena’s Latest Movie Release Date, Cast, and Trailer
Netflix’s recent and upcoming film, Little Brother, is grabbing the attention of both comedy movie lovers and WWE fans because...